Immunovant
Isha Bhatt M.S is a seasoned professional in the field of quality control and assurance, currently serving as Senior Manager Quality Control at Immunovant since January 2022. Previous roles include Quality Control Stability Coordinator at FUJIFILM Diosynth Biotechnologies and Quality Assurance Quality Control at Sagis, PLLC, where adherence to CLIA regulated standards was emphasized. Isha has extensive experience in stability studies, protocol creation, and compliance with cGMP and FDA regulations, having worked at Eli Lilly and Company and ImClone Systems. Educational credentials include a Master’s Degree in Biotechnology from Kean University and a B.S. in Biology from Stockton University.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.